期刊
BMC NEPHROLOGY
卷 24, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12882-022-03000-5
关键词
Galloway-Mowat syndrome; LAGE3 gene; Early-onset nephrotic syndrome; Focal segmental glomerulosclerosis; Steroid-resistant nephrotic syndrome
This article describes a rare genetic disease called GAMOS2 caused by a mutation in the LAGE3 gene. The disease is characterized by early onset nephrotic syndrome, microcephaly, growth retardation, hypotonia, and hypothyroidism. The study identified a large family with this LAGE3 mutation, with mild symptoms compared to other pathogenic genes.
BackgroundGalloway-Mowat syndrome (GAMOS) is a group of rare hereditary diseases by the combination of early onset steroid-resistant nephrotic syndrome (SRNS) and microcephaly with brain anomalies caused by WDR73, LAGE3, OSGEP, TP53RK, TPRKB, GON7, WDR4 or NUP133 mutations.Case presentationWe present the clinical and genetic features of a two-year-old boy with early nephrotic syndrome, microcephaly, growth retardation hypotonia and hypothyroidism. Genetic testing showed the presence of a canonical-splice mutation in the LAGE3 gene (NM_006014: c.188 + 1C > T). A total of nine female members of the family carried the variant. Seven male members died prematurely, and three of them suffered from nephrotic syndrome, which is consistent with the x-linked gene map of the disease. The overall symptoms of the disease due to the LAGE3 mutation were mild compared to other pathogenic genes.ConclusionAs far as we know, this is the largest family case of GAMOS2 caused by LAGE3 mutation found so far. We also compared other subtypes of GAMOS. Due to the heterogeneity of the renal phenotype, regular proteinuria screening is recommended for all patients diagnosed with GAMOS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据